Mezigdomide Plus Ixazomib and Dexamethasone for Relapsed and Refractory Multiple Myeloma

Condition:   Relapsed and Refractory Multiple Myeloma Interventions:   Drug: Mezigdomide;   Drug: Ixazomib;   Drug: Dexamethasone Sponsors:   Kathleen Dorritie;   Bristol-Myers Squibb Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials